Log in | Register

Principles of antimicrobial stewardship for bacterial and fungal infections in ICU

Matteo Bassetti| Marin H. Kollef| Garyphallia Poulakou
Focus editorial
Volume 43, Issue 12 / December , 2017

Pages 1894 - 1897

No abstract available.

References

  1. Bassetti M, De Waele JJ, Eggimann P, Garnacho-Montero J, Kahlmeter G, Menichetti F, Nicolau DP, Paiva JA, Tumbarello M, Welte T, Wilcox M, Zahar JR, Poulakou G (2015) Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria. Intensive Care Med 41:776–795. doi:10.1007/s00134-015-3719-z
  2. Liu VX, Fielding-Singh V, Greene JD, Baker JM, Iwashyna TJ, Bhattacharya J, Escobar GJ (2017) The timing of early antibiotics and hospital mortality in sepsis. Am J Respir Crit Care Med. doi:10.1164/rccm.201609-1848OC(Epub ahead of print)
  3. Barbier F, Luyt CE (2016) Understanding resistance. Intensive Care Med 42:2080–2083. doi:10.1007/s00134-016-4543-9
  4. Hansen V, Oren E, Dennis LK, Brown HE (2016) Infectious disease mortality trends in the United States, 1980-2014. JAMA 316:2149–2151. doi:10.1001/jama.2016.12423
    • View reference on publisher's website
    • View reference on PubMed
  5. Garnacho-Montero J, Dimopoulos G, Poulakou G, Akova M, Cisneros JM, De Waele J, Petrosillo N, Seifert H, Timsit JF, Vila J, Zahar JR, Bassetti M, European Society of Intensive Care Medicine (2015) Task force on management and prevention of Acinetobacter baumannii infections in the ICU. Intensive Care Med 41:2057–2075. doi:10.1007/s00134-015-4079-4
  6. Poulakou G, Plachouras D (2016) Planet’s population on the move, infections on the rise. Intensive Care Med 42:2055–2058. doi:10.1007/s00134-016-4580-4
  7. Bretonnière C, Leone M, Milési C et al (2015) Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric). Intensive Care Med 41:1181–1196. doi:10.1007/s00134-015-3853-7
  8. Mimoz O, Chopra V, Timsit JF (2016) What’s new in catheter-related infection: skin cleansing and skin antisepsis. Intensive Care Med 42:1784–1786
  9. Mimoz O, Chopra V, Widmer A (2016) What’s new in skin antisepsis for short-term intravascular catheters: new data to address old problems? Intensive Care Med 42:2043–2045
  10. Mimoz O, Lucet JC, Kerforne T, Pascal J, Souweine B, Goudet V, Mercat A, Bouadma L, Lasocki S, Alfandari S, Friggeri A, Wallet F, Allou N, Ruckly S, Balayn D, Lepape A, Timsit JF (2015) Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheterrelated infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial. Lancet 386:2069–2077
    • View reference on publisher's website
    • View reference on PubMed
  11. Writing Group for the CHECKLIST-ICU Investigators and the Brazilian Research in Intensive Care Network (BRICNet), Cavalcanti AB, Bozza FA, Machado FR, Salluh JI, Campagnucci VP, Vendramim P, Guimaraes HP, Normilio-Silva K, Damiani LP, Romano E, Carrara F, Diniz Lubarino, de Souza J, Silva AR, Ramos GV, Teixeira C, Brandão da Silva N, Chang CC, Angus DC, Berwanger O (2016) Effect of a quality improvement intervention with daily round checklists, goal setting, and clinician prompting on mortality of critically ill patients: a randomized clinical trial. JAMA 315:1480–1490
    • View reference on publisher's website
  12. Martínez ML, Ferrer R, Torrents E, Guillamat-Prats R, Gomà G, Suárez D, Álvarez-Rocha L, Pozo Laderas JC, Martín-Loeches I, Levy MM, Artigas A, Edusepsis Study Group (2017) Impact of source control in patients with severe sepsis and septic shock. Crit Care Med 45:11–19
    • View reference on publisher's website
    • View reference on PubMed
  13. Lagunes L, Rey-Pérez A, Martín-Gómez MT, Vena A, de Egea V, Muñoz P, Bouza E, Díaz-Martín A, Palacios-García I, Garnacho-Montero J, Campins M, Bassetti M, Rello J (2017) Association between source control and mortality in 258 patients with intra-abdominal candidiasis: a retrospective multi-centric analysis comparing intensive care versus surgical wards in Spain. Eur J Clin Microbiol Infect Dis 36:95–104. doi:10.1007/s10096-016-2775-9
    • View reference on publisher's website
    • View reference on PubMed
  14. Chakrabarti A, Sood P, Rudramurthy SM, Chen S, Kaur H, Capoor M, Chhina D, Rao R, Eshwara VK, Xess I, Kindo AJ, Umabala P, Savio J, Patel A, Ray U, Mohan S, Iyer R, Chander J, Arora A, Sardana R, Roy I, Appalaraju B, Sharma A, Shetty A, Khanna N, Marak R, Biswas S, Das S, Harish BN, Joshi S, Mendiratta D (2015) Incidence, characteristics and outcome of ICU-acquired candidemia in India. Intensive Care Med 41(2):285–295
  15. Bassetti M, Righi E, Ansaldi F, Merelli M, Scarparo C, Antonelli M, Garnacho-Montero J, Diaz-Martin A, Palacios-Garcia I, Luzzati R, Rosin C, Lagunes L, Rello J, Almirante B, Scotton PG, Baldin G, Dimopoulos G, Nucci M, Munoz P, Vena A, Bouza E, de Egea V, Colombo AL, Tascini C, Menichetti F, Tagliaferri E, Brugnaro P, Sanguinetti M, Mesini A, Sganga G, Viscoli C, Tumbarello M (2015) A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality. Intensive Care Med 41(9):1601–1610. doi:10.1007/s00134-015-3866-2
  16. Bassetti M, Garnacho-Montero J, Calandra T, Kullberg B, Dimopoulos G, Azoulay E, Chakrabarti A, Kett D, Leon C, Ostrosky-Zeichner L, Sanguinetti M, Timsit JF, Richardson MD, Shorr A, Cornely OA (2017) Intensive care medicine research agenda on invasive fungal infection in critically ill patients. Intensive Care Med. doi:10.1007/s00134-017-4731-2
  17. Martín-Mazuelos E, Loza A, Castro C, Macías D, Zakariya I, Saavedra P, Ruiz-Santana S, Marín E, León C (2015) β-d-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis. Intensive Care Med 41(8):1424–1432
  18. Bailly S, Leroy O, Montravers P, Constantin JM, Dupont H, Guillemot D, Lortholary O, Mira JP, Perrigault PF, Gangneux JP, Azoulay E, Timsit JF (2015) Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data. Intensive Care Med 41(11):1931–1940

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement